drugset / Trial / NCT00110500
Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy
Non-randomizedSingle-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the clinical and laboratory safety of SB-509 when given as a single treatment by an intramuscular injection to subjects with diabetic neuropathy.
Timeline
- Start
- 2005-04
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hVEGF-A | Unknown | — | Intramuscular |